NewAmsterdam Pharma Company NV Ordinary Shares

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$2,127
$1,298
$1,594
$1,877
Gross Profit
2,109
1,298
1,594
1,877
EBITDA
-49,061
-51,401
-44,290
-47,959
EBIT
-49,078
-51,415
-44,295
-47,965
Net Income
-36,413
-86,893
-42,538
-46,087
Net Change In Cash
2,127
1,298
1,594
1,877
Free Cash Flow
-50,492
-51,165
-32,497
-35,331
Cash
401,333
414,927
309,366
Basic Shares
94,711
82,160
82,477
82,477

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$12,762
$95,905
$0
$0
Gross Profit
12,718
95,905
-14
EBITDA
-165,687
-3,313
-30,726
-5,428
EBIT
-165,731
-3,321
-30,730
-5,429
Net Income
-160,269
-21,137
-36,712
-5,749
Net Change In Cash
12,762
95,905
0
0
Free Cash Flow
-128,346
7,959
-25,184
-5,983
Cash
309,366
438,522
53,092
7,861
Basic Shares
82,161
18,966
17,751
17,751

Earnings Calls

Quarter EPS
2024-06-30
-$0.41
2024-03-31
-$1.06
2023-12-31
-$0.54
2023-09-30
-$0.56